XML 55 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Equity Investments (Tables)
12 Months Ended
Jul. 31, 2023
Cash and Cash Equivalents [Abstract]  
Schedule of Equity Investments

Equity investments consist of the following:

 

July 31
(in thousands)
  2023   2022 
Zedge, Inc. Class B common stock, 42,282 shares at July 31, 2023 and 2022  $89   $117 
Rafael Holdings, Inc. Class B common stock, 278,810 and 290,214 shares at July 31, 2023 and 2022, respectively   558    586 
Other marketable equity securities   1,497    4,089 
Fixed income mutual funds   4,054    12,299 
Current equity investments  $6,198   $17,091 
           
Visa Inc. Series C Convertible Participating Preferred Stock (“Visa Series C Preferred”)  $1,263   $1,132 
Visa Inc. Series A Convertible Participating Preferred Stock (“Visa Series A Preferred”)       1,230 
Convertible preferred stock—equity method investment   2,784    1,001 
Hedge funds   3,002    3,238 
Other   2,825    825 
Noncurrent equity investments  $9,874   $7,426 
Schedule of Carrying Value of Equity Investments

The changes in the carrying value of the Company’s equity investments without readily determinable fair values for which the Company elected the measurement alternative was as follows:

 

Year ended July 31
(in thousands)
  2023   2022   2021 
Balance, beginning of period  $1,501   $2,743   $4,109 
Redemption for Visa mandatory release assessment       (1,230)   (1,870)
Purchase       100     
Adjustment for observable transactions involving a similar investment from the same issuer   131    (103)   510 
Redemptions       (9)   (6)
Impairments            
BALANCE, END OF PERIOD  $1,632   $1,501   $2,743 
Schedule of Unrealized (losses) Gains for All Equity Investments

Unrealized losses and gains for all equity investments measured at fair value included the following:

 

Year ended July 31
(in thousands)
  2023   2022   2021 
Net (losses) gains recognized during the period on equity investments  $(2,613)  $(19,248)  $8,830 
Less: net gains recognized during the period on equity investments sold during the period   18    10    1,090 
Unrealized (losses) gains recognized during the period on equity investments still held at the reporting date  $(2,631)  $(19,258)  $7,740 

 

The unrealized losses and gains for all equity investments measured at fair value in the table above included the following:

 

Year ended July 31
(in thousands)
  2023   2022   2021 
Unrealized (losses) gains recognized during the period on equity investments:               
Rafael Class B common stock  $(7)  $(14,101)  $8,291 
Zedge Class B common stock  $(28)  $(533)  $591 
Summary of Changes in Equity Method Investments

The following table summarizes the change in the balance of the Company’s equity method investment:

 

                
Year ended July 31
(in thousands)
  2023   2022   2021 
Balance, beginning of period  $1,001   $2,901   $ 
Purchase of convertible preferred stock   840    1,051    4,000 
Conversion of secured promissory notes into convertible preferred stock   4,038         
Equity in the net loss of investee   (2,153)   (2,224)   (816)
Amortization of equity method basis difference   (942)   (727)   (283)
BALANCE, END OF PERIOD  $2,784   $1,001   $2,901 
Summary of Statements of Operations

Summarized financial information of the EMI was as follows:

  

July 31
(in thousands)
  2023   2022 
Current assets  $3,661   $3,911 
Noncurrent assets  $2,245   $2,462 
Current liabilities  $(2,771)  $(11,480)
Noncurrent liabilities  $   $ 

 

(in thousands)  Year ended July 31, 2023   Year ended July 31, 2022   From the date of acquisition to July 31, 2021 
REVENUES  $7,998   $7,889   $1,898 
COSTS AND EXPENSES:               
Direct cost of revenues   6,680    9,451    1,937 
Selling, general and administrative   7,871    5,834    3,388 
TOTAL COSTS AND EXPENSES   14,551    15,285    5,325 
LOSS FROM OPERATIONS   (6,553)   (7,396)   (3,427)
Other (expense) income, net   (1,305)   (342)   101 
NET LOSS  $(7,858)  $(7,738)  $(3,326)